Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2021 How Should Clinicians Execute Critical Force Interventions With Compassion, Not Just Harm Minimization, as a Clinical and Ethical Goal? Robert L. Trestman, PhD, MD and Kishore Nagaraja, MD Establishing criteria for compassion maximization would help us do better than harm minimization. AMA J Ethics. 2021;23(4):E292-297. doi: 10.1001/amajethics.2021.292. Case and Commentary Jun 2021 Trauma-Informed Caring for Native American Patients and Communities Prioritizes Healing, Not Management Michael J. Oldani, PhD, MS and Deidre Prosen, MFA, MS Clinicians must express humility, understand local culture, collaborate, and develop an insider’s perspective on past and present life. AMA J Ethics. 2021;23(6):E446-455. doi: 10.1001/amajethics.2021.446. Case and Commentary Jun 2021 How Should Clinicians Help Patients Navigate “Model Minority” Demands? Nellie Tran, PhD, Kevin Yabes, MS, and Arianne Miller, PhD The model minority myth has far-reaching implications for Asian Americans in many settings, including medicine. AMA J Ethics. 2021;23(6):E456-464. doi: 10.1001/amajethics.2021.456. Case and Commentary Jun 2021 How Should Clinicians Respond to Children in Transgenerationally Traumatized Families? Diego Chaves-Gnecco, MD, MPH Pediatricians have obligations to find causes of children’s stress and respond with care to their clinical and social vulnerabilities. AMA J Ethics. 2021;23(6):E465-470. doi: 10.1001/amajethics.2021.465. Medicine and Society Jun 2021 What Does It Mean to Heal From Historical Trauma? Natalie Avalos, PhD Responding well means navigating ongoing grief, restoring self-community and human-ecological relationships, and generating cultural vibrancy. AMA J Ethics. 2021;23(6):E494-498. doi: 10.1001/amajethics.2021.494. Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519. Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712. Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Apr 2021 How Should Clinicians Execute Critical Force Interventions With Compassion, Not Just Harm Minimization, as a Clinical and Ethical Goal? Robert L. Trestman, PhD, MD and Kishore Nagaraja, MD Establishing criteria for compassion maximization would help us do better than harm minimization. AMA J Ethics. 2021;23(4):E292-297. doi: 10.1001/amajethics.2021.292.
Case and Commentary Jun 2021 Trauma-Informed Caring for Native American Patients and Communities Prioritizes Healing, Not Management Michael J. Oldani, PhD, MS and Deidre Prosen, MFA, MS Clinicians must express humility, understand local culture, collaborate, and develop an insider’s perspective on past and present life. AMA J Ethics. 2021;23(6):E446-455. doi: 10.1001/amajethics.2021.446.
Case and Commentary Jun 2021 How Should Clinicians Help Patients Navigate “Model Minority” Demands? Nellie Tran, PhD, Kevin Yabes, MS, and Arianne Miller, PhD The model minority myth has far-reaching implications for Asian Americans in many settings, including medicine. AMA J Ethics. 2021;23(6):E456-464. doi: 10.1001/amajethics.2021.456.
Case and Commentary Jun 2021 How Should Clinicians Respond to Children in Transgenerationally Traumatized Families? Diego Chaves-Gnecco, MD, MPH Pediatricians have obligations to find causes of children’s stress and respond with care to their clinical and social vulnerabilities. AMA J Ethics. 2021;23(6):E465-470. doi: 10.1001/amajethics.2021.465.
Medicine and Society Jun 2021 What Does It Mean to Heal From Historical Trauma? Natalie Avalos, PhD Responding well means navigating ongoing grief, restoring self-community and human-ecological relationships, and generating cultural vibrancy. AMA J Ethics. 2021;23(6):E494-498. doi: 10.1001/amajethics.2021.494.
Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519.
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582.
History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.
Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750.